A Clinical Consensus Approach to Developing a New Funding Model for Radiation Services in Ontario.


Journal

Healthcare quarterly (Toronto, Ont.)
ISSN: 1710-2774
Titre abrégé: Healthc Q
Pays: Canada
ID NLM: 101208192

Informations de publication

Date de publication:
Jul 2023
Historique:
medline: 14 8 2023
pubmed: 13 8 2023
entrez: 12 8 2023
Statut: ppublish

Résumé

In 2021, Ontario Health (Cancer Care Ontario) introduced a quality-based procedure model for the funding of radiation treatment (RT) in Ontario. This model ties reimbursement to patient care activities, ensuring equity and transparency in funding. Over 200 RT interprofessionals (oncologists, therapists and physicists) participated on 22 expert panels to establish or identify 288 evidence-based RT protocols and 672 quality expectations (QEs) to optimally deliver RT, which eventually led to the micro-costing of all protocols. Iterative review is required to ensure updated techniques and identify evolving standards of care, thereby providing the highest quality of RT care to Ontarians.

Identifiants

pubmed: 37572070
pii: hcq.2023.27146
doi: 10.12927/hcq.2023.27146
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

37-42

Informations de copyright

Copyright © 2023 Longwoods Publishing.

Auteurs

Suzanna Apostolovski (S)

A lead with the Performance and Accountability team (clinical program) at Ontario Health in Toronto, ON, and has previously worked with the Radiation Treatment Program (RTP). She is also working to improve health services research and enhance communication strategies and knowledge translation for women diagnosed with ductal carcinoma in situ.

Farzana McCallum (F)

Manager of the Performance and Accountability team (clinical programs) at Ontario Health in Toronto, ON, and has previously worked with the RTP. She is working to ensure high-quality care for all Ontarians.

Carina Simniceanu (C)

A lead with the RTP at Ontario Health (Cancer Care Ontario) (OH [CCO]) in Toronto, ON, supporting provincial quality improvement initiatives with provincial RT stakeholders.

Julie Kraus (J)

A team lead with the RTP at OH (CCO) specializing in healthcare quality improvement and project management for clinical programs at the provincial level in Toronto, ON. She also has a clinical background as a registered dietitian.

Eric Gutierrez (E)

A medical radiation therapist with over 30 years of experience in Ontario and Quebec. In his role as a manager for the RTP at OH (CCO) in Toronto, ON, he has led countless quality improvement projects and initiatives to support improved patient care.

Brian Liszewski (B)

A radiation therapist and advisor for Radiation Therapy and Infrastructure Planning at OH (CCO) in Toronto, ON, supporting capacity planning and the provincial RTP.

Emma Esselink (E)

A senior specialist in the Symptom Management Program at Ontario Health in Toronto, ON. She has worked in the health and mental healthcare field.

Jean-Pierre Bissonnette (JP)

The associate head of Professional and Academic Affairs in the Department of Medical Physics at the Princess Margaret Cancer Centre in Toronto, ON. His research interests include dose reconstruction based on image guidance and image-based adaptation of therapy.

Margaret Hart (M)

Has been a medical radiation therapist since 1994 and a clinical quality lead with the RTP at OH (CCO) in Toronto, ON.

Michael Brundage (M)

A radiation oncologist and professor of Oncology at the Department of Public Health Sciences at Queen's University in Kingston, ON. His research program resides primarily within the Division of Cancer Care and Epidemiology at Queen's Cancer Research Institute.

Padraig Warde (P)

A professor in the Department of Radiation Oncology, University of Toronto, as well as a staff radiation oncologist at the Princess Margaret Cancer Centre in Toronto, ON. His clinical interests include locally advanced prostate cancer, testicular seminoma and clinical trials.

Jason Pantarotto (J)

The provincial head of the RTP at OH (CCO) and an associate professor within the Faculty of Medicine, University of Ottawa, in Ottawa, ON. He has research interests in ablative radiotherapy for chest and abdominal tumours, advanced radiotherapy techniques for moving tumours and integrated cancer delivery.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH